【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 3423次   下载 3113 本文二维码信息
码上扫一扫!
前列腺癌PSA特异性树突状细胞瘤苗的构建及其体外免疫活性的观察
徐丹枫*,高轶,刘玉杉*,崔心刚,车建平,阴雷,邢继章,姚亚成,任吉忠,闵志廉
0
(第二军医大学长征医院泌尿外科,全军泌尿外科中心,上海 200003)
摘要:
目的:构建前列腺癌PSA特异性树突状细胞(PSADC)瘤苗,并观察其体外免疫活性,为后续研究奠定基础。方法:分离骨髓前体细胞,大量制备骨髓DCs(bone marrow derived DC,BMDC);分别以PSA、癌细胞裂解产物(lysate,Lys)、无关蛋白卵清蛋白(Ova)冲击DC制备PSADC、LysDC、OvaDC瘤苗。ELISA法检测PSADC瘤苗培养上清中细胞因子(IL12 p70和IL1β)水平的变化;观察PSADC瘤苗刺激抗原特异性T细胞增殖活性和诱导抗原特异性CTL杀伤活性,并与LysDC、OvaDC瘤苗及未加入抗原冲击的DC(NonDC)组作比较。结果:成功获得成熟DC,纯度可以达到>95%。ELISA法检测结果表明,PSADC、LysDC和OvaDC组培养上清中IL12 p70和IL1β水平均较NonDC组明显升高(P<0.05)。混合淋巴细胞培养(MLR)显示:PSADC、LysDC组DCs刺激CD4+T细胞增殖的能力明显优于OvaDC、NonDC组(P<0.01);PSADC、LysDC组培养上清中IL2、IFNγ水平明显高于后两者(P<0.01),而IL10和IL4水平下调(P<0.05)。PSADC、LysDC组可产生针对PSA和肿瘤裂解物的DTH反应,而对无关抗原无效(P<0.05)。与OVADC、NonDC组相比,LysDC、PSADC组体外诱导的CTL细胞对LNCaP细胞的杀伤活性较强 (P<0.05),且具有抗原特异性。结论:利用PSA蛋白冲击DC可成功制备PSA特异性DC瘤苗,该瘤苗体外具有较强的免疫活性,能有效杀伤LNCaP细胞。
关键词:  树突细胞  前列腺特异抗原  前列腺癌  癌症疫苗  细胞毒性T淋巴细胞
DOI:10.3724/SP.J.1008.2009.0265
投稿时间:2007-12-14修订日期:2008-09-16
基金项目:上海市科委基金(044119615).
Construction of PSA specific dendritic cell vaccine and its in vitro immune activity
XU Danfeng*, GAO Yi, LIU Yushan*, CUI Xingang, CHE Jianping, YIN Lei, XING Jizhang, YAO Yacheng, REN Jizhong, MIN Zhilian
(Department of Urology, Urology Center of PLA, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China)
Abstract:
Objective:To construct of PSAspecific dendritic cell (DC) vaccine and to observe its in vitro antitumour activity, so as to pave a way for future study. Methods: Bone marrow precursors were isolated and bone marrow derived DCs were prepared. Mature DCs were pulsed by PSA, Lysate of cancer cells, OVA and PBS to yield PSADC, Lys DC, OvaDC, and NonDC, respectively. After primed by antigen, the changes of IL12 p70 and IL1β in the supernatant of dendritic cells were assessed by ELISA. The antigenspecific proliferation and cytotoxicity activity of T cellprimed by PSApulsed DCs were observed and the results were compared with those by Lys, Ova and PBSpulsed DCs. Results: Mature DCs were successfully derived from bone marrow cells with a purity higher than 95%. ELISA assay showed PSADC, LysDC and OvaDC group secreted high levels of IL12 p70 and IL1β than NonDC group (P<0.05). In addition, PSADCs and LysDCs had significantly stronger ability to stimulate the proliferation of CD4+T cells in 3day classic mixed lymphocyte reaction (MLR) compared with OvaDCs and NonDCs (P<0.01). Higher levels of IFNγ and IL2 were detected in PSADCs and LysDCs groups compared with the other two groups (P<0.01), whereas the levels of IL10 and IL4 were lower than the other two groups (P<0.05). Moreover, PSADCs and Lys DCs enhanced DTH responses of C57BL/6 mice after antigen immunization; the third antigen and control did not show the enhancement effect (P<0.05). To observe the in vitro antiPSA CTL reactions induced by PSADCs and LysDCs, the LNCaP cell line (PSA specific) was used as syngeneic target and the E.G7 cell line (H2b) was used as Ovaspecific target cells. Compared with OvaDCs and NonDCs, CTL cells induced by PSADCs, LysDCs had significantly enhanced antigenspecific CTL activity to LNCaP cells (P<0.05).Conclusion: DCbased PSAepitope vaccine can be prepared by pulsing DCs with PSA protein; the prepared vaccine has strong in vitro immune activity and can kill LNCaP cells.
Key words:  dendritic cells  prostate specific antigen  prostatic neoplasms  cancer vaccines  cytotoxic T lymphocytes